190 filings
Page 4 of 10
8-K
142zklk
6 Feb 20
Departure of Directors or Certain Officers
9:22am
8-K
4gtp0lq10zooixxw
20 Dec 19
Departure of Directors or Certain Officers
4:15pm
8-K
aho25
10 Oct 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
gwg1 1m4rkr498r
16 Sep 19
NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors
4:30pm
8-K
h1eme6g4fb53yi3o
13 Aug 19
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
7h4r8 ulk8rz8w7
9 Aug 19
NovaBay Pharmaceuticals Announces Pricing of $4.2 Million Registered Direct Offering
9:02am
8-K
uxrj wvsicc2d9h0cp
7 Aug 19
NovaBay Pharmaceuticals Reports 2019 Second Quarter Financial Results
8:00am
8-K
stutc821
29 Jul 19
NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million
8:30am
8-K
phn1n5tw xsv9k
25 Jul 19
Departure of Directors or Certain Officers
4:30pm
8-K
k93k9ko
15 Jul 19
NovaBay Pharmaceuticals Issues Letter to Stockholders
8:30am
8-K
v6wlxply
1 Jul 19
Other Events
8:32am
8-K
wxt9my635s4lzse
26 Jun 19
Entry into a Material Definitive Agreement
4:31pm
8-K
9bap4tgz3kub3umye
19 Jun 19
Entry into a Material Definitive Agreement
8:30am
8-K
cc4xxz5dzl3phdmr1n
17 Jun 19
NovaBay Pharmaceuticals Appoints Justin Hall President and CEO, and Jason Raleigh CFO
8:31am
8-K
e1l0t67l
3 Jun 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
bq8ox 4x1
21 May 19
NovaBay Pharmaceuticals Receives NYSE American Communication
4:50pm
8-K
jjvi5jpz
13 May 19
NovaBay Pharmaceuticals Reports First Quarter 2019 Financial Results
4:30pm
8-K
b67bgj8nbp90tici7 ho
3 May 19
Departure of Directors or Certain Officers
4:30pm
8-K
5dd4ck7xl no
15 Apr 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
wc7rg 9bwrwns
1 Apr 19
NovaBay Pharmaceuticals Announces Investments of $5 Million to Support U.S. Avenova Commercialization Strategy
9:17am